187 related articles for article (PubMed ID: 14962108)
1. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
Wolf P; Kreimer-Erlacher H; Seidl H; Bäck B; Soyer HP; Kerl H
J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
3. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
[TBL] [Abstract][Full Text] [Related]
4. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Kerl H; Wolf P
Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.
Stern RS; Bolshakov S; Nataraj AJ; Ananthaswamy HN
J Invest Dermatol; 2002 Aug; 119(2):522-6. PubMed ID: 12190879
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
7. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
Gasparro FP; Liao B; Foley PJ; Wang XM; McNiff JM
Environ Mol Mutagen; 1998; 31(2):105-12. PubMed ID: 9544188
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
9. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
Nataraj AJ; Wolf P; Cerroni L; Ananthaswamy HN
J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
[TBL] [Abstract][Full Text] [Related]
10. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin.
Kress S; Sutter C; Strickland PT; Mukhtar H; Schweizer J; Schwarz M
Cancer Res; 1992 Nov; 52(22):6400-3. PubMed ID: 1423288
[TBL] [Abstract][Full Text] [Related]
11. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
[TBL] [Abstract][Full Text] [Related]
12. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA.
Wang XM; McNiff JM; Klump V; Asgari M; Gasparro FP
Photochem Photobiol; 1997 Aug; 66(2):294-9. PubMed ID: 9277151
[TBL] [Abstract][Full Text] [Related]
13. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
14. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
15. Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers.
Nataraj AJ; Black HS; Ananthaswamy HN
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7961-5. PubMed ID: 8755585
[TBL] [Abstract][Full Text] [Related]
16. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice.
Nomura T; Nakajima H; Hongyo T; Taniguchi E; Fukuda K; Li LY; Kurooka M; Sutoh K; Hande PM; Kawaguchi T; Ueda M; Takatera H
Cancer Res; 1997 Jun; 57(11):2081-4. PubMed ID: 9187098
[TBL] [Abstract][Full Text] [Related]
17. Photoreactivation does not alter ras and p53 mutation spectra in ultraviolet radiation-induced corneal sarcomas of Monodelphis domestica.
Kusewitt DF; Preble NE; Bonnett CD
Mol Carcinog; 2000 Feb; 27(2):117-24. PubMed ID: 10657904
[TBL] [Abstract][Full Text] [Related]
18. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice.
van Kranen HJ; de Gruijl FR; de Vries A; Sontag Y; Wester PW; Senden HC; Rozemuller E; van Kreijl CF
Carcinogenesis; 1995 May; 16(5):1141-7. PubMed ID: 7767977
[TBL] [Abstract][Full Text] [Related]
19. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
Stern RS; Bagheri S; Nichols K;
J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
[TBL] [Abstract][Full Text] [Related]
20. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas.
Spencer JM; Kahn SM; Jiang W; DeLeo VA; Weinstein IB
Arch Dermatol; 1995 Jul; 131(7):796-800. PubMed ID: 7611795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
